Indian Vinblastine Exporters: Complete Supplier Ranking with Market Share — 244 Manufacturers (2026) — TransData Nexus

Q: Who is the largest vinblastine buyer importing from India?

HIRAD PHRAMED (IRAN) is the largest vinblastine importer from India with a 5.7% market share and import value of $42.4K.

Q: How many vinblastine buyers import from India?

There are 244 active vinblastine buyers importing from India, with a combined import market of $750.1K across 573 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top vinblastine buyers from India?

The top 5 vinblastine buyers — HIRAD PHRAMED, EXP CODE, GLORINCOR PHARMACEUTICALS OOO, LABORATORIOS KAMPAR S.A., IMPORT MANAGER CLIENT CODE — together control 19.3% of total vinblastine import value from India.

Suresh Sormare

Vinblastine

India Pharmaceutical Trade Intelligence

$750.1K140 Suppliers96 CountriesHS 30049043

ExportsIndia → COLOMBIA9.6%India → IRAN9.3%

ImportsAUSTRALIA → India$1.1K

#1 Supplier: NAPROD LIFE

Market Analysis: Top Importing Countries & Their Importers

1Colombia

Colombia emerges as the first largest importing country, achieving a total trade value of $72.2K through 0 shipments. This represents a market share of 9.6% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Colombia demonstrates strong market positioning with an average shipment value of $72.2K, indicating premium pricing strategy compared to the market average of $1.3K.

Colombia is a key market for Vinblastine imports, representing 9.6% of total trade value.

Primary Market

Secondary Market

2Iran

Iran emerges as the second largest importing country, achieving a total trade value of $70.0K through 2 shipments. This represents a market share of 9.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Iran has a diverse importer base, with their top importers including:

• HIRAD PHRAMED - $42.4K (60.7% of country's total business)

Buyer Segment Analysis

TransData Nexus Vinblastine buyer market intelligence

1Buyer Segment Analysis

The importation of Vinblastine from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like HIRAD PHRAMED in Iran and GLORINCOR PHARMACEUTICALS OOO in Belarus function as intermediaries, procuring Vinblastine in bulk to supply to healthcare providers. Their order patterns are characterized by large volumes and regular intervals to maintain a steady supply chain.

Hospital Groups: Organizations such as LABORATORIOS KAMPAR S.A. in Chile and PHARMACEUTICAL DISTOLOZA S.A. in Peru represent hospital networks that import Vinblastine directly for patient treatment. Their purchasing is driven by patient demand and treatment protocols, leading to variable order sizes and frequencies.

Government Procurement Agencies: Entities like the ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY in Kenya are responsible for national healthcare procurement. They often engage in tender-based purchasing, resulting in large, periodic orders aligned with government healthcare initiatives and budget cycles.

Re-exporters: Companies such as IMPORT MANAGER CLIENT CODE in Lebanon may act as re-exporters, importing Vinblastine for redistribution to neighboring regions. Their buying behavior includes bulk purchases with a focus on market demand and regional distribution strategies.

Country-Specific Import Regulations

TransData Nexus Vinblastine buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Vinblastine from India, the import regulations are as follows:

1. Colombia:

Regulatory Authority: Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA).

Import Registration Process: Requires submission of a sanitary registration application, including product details, manufacturing processes, and quality control measures.

Estimated Timeline: Approximately 6 to 12 months, depending on the completeness of the application and any required inspections.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049043 are generally subject to a 5% import duty, with potential exemptions under specific trade agreements.

2. Iran:

Regulatory Authority: Iran Food and Drug Administration (IFDA).

Import Registration Process: Involves obtaining an import license, providing detailed product dossiers, and compliance with national pharmaceutical standards.

Demand Drivers & Market Opportunity

TransData Nexus Vinblastine buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Vinblastine in importing countries is influenced by several key factors:

Disease Prevalence: Vinblastine is primarily used in the treatment of various cancers, including Hodgkin's lymphoma and testicular cancer. The prevalence of these conditions in countries like Colombia, Iran, and Thailand drives the need for effective chemotherapy agents.

Government Healthcare Programs: Many countries have national health initiatives aimed at improving cancer care. For instance, Thailand's Universal Coverage Scheme provides access to essential medicines, including chemotherapy agents, thereby increasing demand for Vinblastine.

WHO Essential Medicines List (EML) Procurement: Vinblastine is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions. This inclusion underscores its importance and encourages its availability in national healthcare systems.

Tender-Based Purchasing: Government and international organizations often procure medicines through tenders to ensure cost-effectiveness and supply security. The presence of 244 buyers across 96 countries, as per TransData Nexus data, indicates a robust market for Vinblastine facilitated by such procurement mechanisms.

Common Questions — Vinblastine Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest vinblastine buyer importing from India?

Based on import volume and value, HIRAD PHRAMED (IRAN) leads with $42.4K in imports and a 5.7% market share — the highest of any single vinblastine importer. EXP CODE (POLAND) and GLORINCOR PHARMACEUTICALS OOO (BELARUS) are the next largest buyers.

QHow many companies buy vinblastine from India?

There are 244 active vinblastine buyers importing from India, with a combined market of $750.1K across 573 shipments to 96 countries. The top 5 buyers hold 19.3% of total import value, while the remaining 239 buyers handle the other 80.7%.

QWhich countries import the most vinblastine from India?

The top importing countries for vinblastine from India are Colombia (9.6%), Iran (9.3%), Poland (8.0%), Thailand (7.9%), Venezuela (6.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of vinblastine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for vinblastine from India?

The average import transaction value for vinblastine from India is $1.3K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Vinblastine buyer market intelligence

1Buyer Segment Analysis

The importation of Vinblastine from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like HIRAD PHRAMED in Iran and GLORINCOR PHARMACEUTICALS OOO in Belarus function as intermediaries, procuring Vinblastine in bulk to supply to healthcare providers. Their order patterns are characterized by large volumes and regular intervals to maintain a steady supply chain.

Hospital Groups: Organizations such as LABORATORIOS KAMPAR S.A. in Chile and PHARMACEUTICAL DISTOLOZA S.A. in Peru represent hospital networks that import Vinblastine directly for patient treatment. Their purchasing is driven by patient demand and treatment protocols, leading to variable order sizes and frequencies.

Government Procurement Agencies: Entities like the ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY in Kenya are responsible for national healthcare procurement. They often engage in tender-based purchasing, resulting in large, periodic orders aligned with government healthcare initiatives and budget cycles.

Re-exporters: Companies such as IMPORT MANAGER CLIENT CODE in Lebanon may act as re-exporters, importing Vinblastine for redistribution to neighboring regions. Their buying behavior includes bulk purchases with a focus on market demand and regional distribution strategies.

Country-Specific Import Regulations

TransData Nexus Vinblastine buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Vinblastine from India, the import regulations are as follows:

1. Colombia:

Regulatory Authority: Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA).

Import Registration Process: Requires submission of a sanitary registration application, including product details, manufacturing processes, and quality control measures.

Estimated Timeline: Approximately 6 to 12 months, depending on the completeness of the application and any required inspections.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049043 are generally subject to a 5% import duty, with potential exemptions under specific trade agreements.

2. Iran:

Regulatory Authority: Iran Food and Drug Administration (IFDA).

Import Registration Process: Involves obtaining an import license, providing detailed product dossiers, and compliance with national pharmaceutical standards.

Demand Drivers & Market Opportunity

TransData Nexus Vinblastine buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Vinblastine in importing countries is influenced by several key factors:

Disease Prevalence: Vinblastine is primarily used in the treatment of various cancers, including Hodgkin's lymphoma and testicular cancer. The prevalence of these conditions in countries like Colombia, Iran, and Thailand drives the need for effective chemotherapy agents.

Government Healthcare Programs: Many countries have national health initiatives aimed at improving cancer care. For instance, Thailand's Universal Coverage Scheme provides access to essential medicines, including chemotherapy agents, thereby increasing demand for Vinblastine.

WHO Essential Medicines List (EML) Procurement: Vinblastine is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions. This inclusion underscores its importance and encourages its availability in national healthcare systems.

Tender-Based Purchasing: Government and international organizations often procure medicines through tenders to ensure cost-effectiveness and supply security. The presence of 244 buyers across 96 countries, as per TransData Nexus data, indicates a robust market for Vinblastine facilitated by such procurement mechanisms.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Vinblastine

Vinblastine

Who Buys Vinblastine from India — 244 Importers Behind a $750.1K Market

Top Vinblastine Importers — Ranked by Import Value

Top Vinblastine Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Vinblastine — and from which countries?

Vinblastine — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Colombia

2Iran

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Vinblastine Buyers & Importers

QWho is the largest vinblastine buyer importing from India?

QHow many companies buy vinblastine from India?

QWhich countries import the most vinblastine from India?

QWhat is the average import order value for vinblastine from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Poland

4Thailand

5Venezuela

Analysis Methodology